The aim of this study was to compare CMC detection using the CellSearch® system and a new EPISPOT assay (S100-EPISPOT assay) designed to identify viable CMCs that secrete S100, a protein expressed and secreted by melanoma cells [22], in blood samples from patients with metastatic melanoma. This evidence concerns the gene S100B and metastatic melanoma.